Improve disease awareness and patient health literacy to enable quicker access to the right specialist, increased knowledge of treatment options and understanding when current treatment stops achieving the desired goals.
LeapUp - Open Innovation Program
Technological innovation has profoundly changed clinical practice and the relationship between health professionals and patients. Aware of this reality and of its role in the healthcare ecosystem, AbbVie is looking to collaborate with promising startups, to gain a clear vision of market trends and to be at the forefront of emerging technologies, open to unexpected novel opportunities that improve people’s lives.
The LeapUp Open Innovation Program aims to create an environment of collaborative innovation with startups that have the right fit with current challenges identified in specific therapeutic areas, giving them the opportunity to apply their projects with a leading client and a powerful brand to add value to the health ecosystem.
Who Are We Looking For?
In this Open Innovation Program, we’re looking for startups that demonstrate the value of their solution to AbbVie Portugal and that can make a significant contribution to improve the lives of people with:
- Atopic Dermatitis
- Inflammatory
- Lymphoma
- Migraine
If you have an innovative solution that meet one of the program challenges and your startup is based in Europe or Israel
At the end of the program, the selected startups can have the opportunity to further grow their business by exploring synergies, co-creating and co-developing new paths and future business opportunities directly with AbbVie Portugal in a Collaborative Partnership.
Check the Program Regulation and if you are a startup from Europe or Israel interested in participating with your solution